Powered by

Merck and Palantir to form JV to advance cancer research

Nov 20, 2018 - Marketline Newswire

Merck has signed a non-binding term sheet to establish a joint venture (JV) with data analytics firm Palantir Technologies to support the advancement of cancer research.

The JV will be known as Syntropy and will focus on empowering scientists and research centres with data integration, as well as analytics technology to advance cancer research.Syntropy intends to provide scientists access to biomedical data available with global research institutions and facilitate the collaboration of exp...